Published in BMC Struct Biol on August 20, 2009
Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). Acta Crystallogr D Biol Crystallogr (2011) 0.94
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol (2011) 0.91
Structural basis for the broad specificity of a new family of amino-acid racemases. Acta Crystallogr D Biol Crystallogr (2013) 0.84
Crystal structure of a zinc-dependent D-serine dehydratase from chicken kidney. J Biol Chem (2011) 0.80
Structure of alanine racemase from Oenococcus oeni with bound pyridoxal 5'-phosphate. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78
Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630. Acta Crystallogr D Biol Crystallogr (2014) 0.78
The structure of alanine racemase from Acinetobacter baumannii. Acta Crystallogr F Struct Biol Commun (2014) 0.76
Crystallization and preliminary X-ray study of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.76
Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Extremophiles (2013) 0.76
Crystal Structure of a Thermostable Alanine Racemase from Thermoanaerobacter tengcongensis MB4 Reveals the Role of Gln360 in Substrate Selection. PLoS One (2015) 0.75
Characterization of Lactobacillus salivarius alanine racemase: short-chain carboxylate-activation and the role of A131. Springerplus (2015) 0.75
Structural and Functional Adaptation of Vancomycin Resistance VanT Serine Racemases. MBio (2015) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Inference of macromolecular assemblies from crystalline state. J Mol Biol (2007) 44.95
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr (2004) 31.52
WHAT IF: a molecular modeling and drug design program. J Mol Graph (1990) 24.35
Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature (2003) 10.38
The Sverdlovsk anthrax outbreak of 1979. Science (1994) 10.29
Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science (2002) 9.83
Anthrax. N Engl J Med (1999) 8.89
3DCoffee: combining protein sequences and structures within multiple sequence alignments. J Mol Biol (2004) 6.01
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell (2005) 3.79
Lysine methylation as a routine rescue strategy for protein crystallization. Structure (2006) 3.14
Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci (2004) 2.70
Homology modeling, model and software evaluation: three related resources. Bioinformatics (1998) 2.47
Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science (2005) 2.39
Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium. J Bacteriol (2003) 2.19
Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W. J Bacteriol (1972) 2.17
Bacillus anthracis aerosols in goat hair processing mills. Am J Hyg (1960) 2.08
Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: an X-ray analysis at 1.8-A resolution. Biochemistry (1993) 1.65
Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9-A resolution. Biochemistry (1997) 1.59
Large-scale evaluation of protein reductive methylation for improving protein crystallization. Nat Methods (2008) 1.55
Thermostable alanine racemase from Bacillus stearothermophilus: molecular cloning of the gene, enzyme purification, and characterization. Biochemistry (1986) 1.34
Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl Environ Microbiol (2006) 1.29
Factors affecting the germination of spores of Bacillus anthracis. J Appl Bacteriol (1987) 1.23
Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol Lett (2001) 1.22
Characterization of the alanine racemases from Pseudomonas aeruginosa PAO1. Curr Microbiol (2000) 1.20
Structure-based drug design. Nature (1996) 1.19
A pivotal role for reductive methylation in the de novo crystallization of a ternary complex composed of Yersinia pestis virulence factors YopN, SycN and YscB. Acta Crystallogr D Biol Crystallogr (2004) 1.16
Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine. Biochemistry (1998) 1.16
Structures of an alanine racemase from Bacillus anthracis (BA0252) in the presence and absence of (R)-1-aminoethylphosphonic acid (L-Ala-P). Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 1.15
A side reaction of alanine racemase: transamination of cycloserine. Biochemistry (2003) 1.15
Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemase. Biochemistry (1999) 1.12
Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallogr D Biol Crystallogr (2006) 1.11
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Crystallization and improvement of crystal quality for x-ray diffraction of maltooligosyl trehalose synthase by reductive methylation of lysine residues. Acta Crystallogr D Biol Crystallogr (1999) 1.11
Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections. Infect Immun (2007) 1.11
The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms. Nat Struct Mol Biol (2005) 1.06
Structural evidence that alanine racemase from a D-cycloserine-producing microorganism exhibits resistance to its own product. J Biol Chem (2004) 1.06
Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs. Genomics Proteomics Bioinformatics (2004) 1.06
Crystal structure at 1.45 A resolution of alanine racemase from a pathogenic bacterium, Pseudomonas aeruginosa, contains both internal and external aldimine forms. Biochemistry (2003) 1.05
Residues Asp164 and Glu165 at the substrate entryway function potently in substrate orientation of alanine racemase from E. coli: Enzymatic characterization with crystal structure analysis. Protein Sci (2008) 1.02
Use of anthrax vaccine in the United States. MMWR Recomm Rep (2000) 1.02
Identification of Bacillus anthracis proteins associated with germination and early outgrowth by proteomic profiling of anthrax spores. Proteomics (2004) 0.98
Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J Bacteriol (2002) 0.97
The potential use of mechanism-based enzyme inactivators in medicine. J Enzyme Inhib (1988) 0.94
X-ray crystallographic analysis of pokeweed antiviral protein-II after reductive methylation of lysine residues. Biochem Biophys Res Commun (2000) 0.91
Structure-based drug design: computational advances. Annu Rev Pharmacol Toxicol (1997) 0.90
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
Dimerization inhibitors of HIV-1 protease. Biol Chem (2002) 0.85
Reductive methylation to improve crystallization of the putative oxidoreductase Rv0765c from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.81
Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates. Bioorg Med Chem Lett (2001) 0.79
Breaking the spell: drug discovery based on modulating protein-protein interactions. Expert Rev Proteomics (2004) 0.79
Bioterrorism--types of epidemics, new epidemiological paradigm and levels of prevention. Public Health (2007) 0.76
Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med (2002) 1.81
Evolutionary fates within a microbial population highlight an essential role for protein folding during natural selection. Mol Syst Biol (2010) 1.14
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Crystal structure at 1.45 A resolution of alanine racemase from a pathogenic bacterium, Pseudomonas aeruginosa, contains both internal and external aldimine forms. Biochemistry (2003) 1.05
The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation. J Mol Biol (2002) 1.02
Reactivity of reduced [2Fe-2S] ferredoxins parallels host susceptibility to nitroimidazoles. Antimicrob Agents Chemother (2003) 0.99
Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). Acta Crystallogr D Biol Crystallogr (2011) 0.94
The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol (2011) 0.91
The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine. J Bacteriol (2007) 0.91
Functionalized viral nanoparticles as ultrasensitive reporters in lateral-flow assays. Analyst (2013) 0.90
Experimental evolution of adenylate kinase reveals contrasting strategies toward protein thermostability. Biophys J (2010) 0.89
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS One (2011) 0.88
Inherent structural disorder and dimerisation of murine norovirus NS1-2 protein. PLoS One (2012) 0.87
Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green. J Mol Recognit (2009) 0.87
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli. BMC Biotechnol (2010) 0.85
N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors. J Antibiot (Tokyo) (2003) 0.84
Crystal structure of Bacteroides thetaiotaomicron TetX2: a tetracycline degrading monooxygenase at 2.8 Å resolution. Proteins (2011) 0.84
Label-free, in situ SERS monitoring of individual DNA hybridization in microfluidics. Nanoscale (2014) 0.82
Detection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay. ACS Appl Mater Interfaces (2015) 0.81
Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnol Lett (2014) 0.80
Rare target enrichment for ultrasensitive PCR detection using cot-rehybridization and duplex-specific nuclease. Anal Biochem (2011) 0.77
Characterization and crystallization of active domains of a novel luciferase from a marine dinoflagellate. Acta Crystallogr D Biol Crystallogr (2003) 0.76
A peroxidase-active aptazyme as an isothermally amplifiable label in an aptazyme-linked oligonucleotide assay for low-picomolar IgE detection. Analyst (2012) 0.76
Detection and typing of viruses using broadly sensitive cocktail-PCR and mass spectrometric cataloging: demonstration with dengue virus. J Mol Diagn (2012) 0.75
Crystallization and preliminary X-ray analysis of the chemokine-binding protein from orf virus (Poxviridae). Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.75
Recovery of small DNA fragments from serum using compaction precipitation. PLoS One (2012) 0.75
Molecular dynamics simulations of Trichomonas vaginalis ferredoxin show a loop-cap transition. Biophys J (2007) 0.75
Biophysical characterization of VEGF-aHt DNA aptamer interactions. Int J Biol Macromol (2013) 0.75
Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med (2005) 0.75